Stay updated on IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page shows a new revision number v3.6.3, replacing the previous v3.6.2; this indicates a small backend/documentation update rather than a substantive change to the study details.SummaryDifference0.0%

- Check15 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a new template/version. This update affects only the page's versioning and does not modify the study details or outcomes.SummaryDifference0.0%

- Check29 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating enrollment for this study has ended. This reflects a closure of participant recruitment.SummaryDifference0.4%

- Check36 days agoChange DetectedRevision history updated to v3.5.5, replacing v3.5.4. This indicates an updated edition of the study documents.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now displays a new site revision tag Revision: v3.5.4, replacing the previous Revision: v3.5.3 in the footer. This reflects a routine deployment update rather than changes to study data.SummaryDifference0.0%

- Check79 days agoChange DetectedClinicalTrials.gov’s page footer has been updated to reflect a new site revision (v3.5.3), replacing the previous one (v3.5.2). This indicates a platform/version update rather than a change to the study record information.SummaryDifference0.0%

Stay in the know with updates to IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page.